Skip to content

Minghua Shan

Bayer (United States)

2 papers in the Anchorcite directory, published between 2007 and 2008, cited 18,093 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Josep Maria Llovet · 1 paper
  • Sergio Ricci · 1 paper
  • Vincenzo Mazzaferro · 1 paper
  • Philip a. Hilgard · 1 paper
  • Edward John Gane · 1 paper
  • Jean Frédéric Blanc · 1 paper
  • André Cosme de Oliveira · 1 paper
  • Armando Santoro · 1 paper

Papers

  1. Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine · 2008 · 13,250 citations

    BACKGROUND: No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in…

  2. Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine · 2007 · 4,843 citations

    BACKGROUND: We conducted a phase 3, randomized, double-blind, placebo-controlled trial of sorafenib, a multikinase inhibitor of tumor-cell proliferation and angiogenesis, in patients with advanced clear-cell renal-cell carcinoma. METHODS: From November 2003 to March 2005, we randomly assigned 903 patients with…

Metadata from OpenAlex (CC0).